KDventures AB (publ) carries out a directed issue of shares to guarantors in connection with the completed rights issue

Core Viewpoint - KDventures AB has announced a directed issue of 5,283,870 series B shares to compensate guarantors for their commitments related to a rights issue, deviating from shareholders' preferential rights [2][3]. Group 1: Directed Issue Details - The directed issue will increase the company's share capital by up to SEK 52,838.70 [3]. - The subscription price for the directed issue is set at SEK 0.31 per share, based on the volume-weighted average price during the rights issue subscription period [4]. - The total claims of the guarantors against the company amount to SEK 1,638,000, which will be settled through the issuance of new shares [4]. Group 2: Impact on Share Capital - After the registration of the directed issue, the total number of series B shares will reach 656,972,867, and the company's total share capital will be SEK 6,595,281.28 [4]. - The dilution effect from this directed issue is approximately 0.8 percent [4]. Group 3: Company Overview - KDventures AB is a Nordic investment company focused on life sciences, investing in innovative pharmaceutical projects and medical technology products from leading research institutions in the Nordic region [7]. - The company aims to create value through a diversified portfolio and active engagement in various stages of development, offering investors exposure to both listed and private life science projects with significant growth potential [7].